<DOC>
	<DOCNO>NCT01292486</DOCNO>
	<brief_summary>The purpose investigation establish hematopoetic stem cell collect new centrifugal blood separator , CaridianBCT 's Spectra Optia Apheresis System , able reconstitute hematopoetic system patient treated myeloablative therapy , equivalent hematopoetic cell harvest predicate COBE® Spectra platform .</brief_summary>
	<brief_title>Evaluation Spectra Optia® Mononuclear Cell Collection Procedure</brief_title>
	<detailed_description>This multi-center ( 3-5 ) single-arm study compare performance Spectra Optia Apheresis System 's MNC protocol historical performance COBE Spectra MNC protocol . In order demonstrate substantial equivalence two device , non-inferiority design use . The study enroll patient multiple myeloma treat myeloablative chemotherapy , follow bone-marrow rescue autologous peripheral blood stem-cell transplant . Peripheral blood stem cell collect use Spectra Optia MNC protocol re-infused follow myeloablative chemotherapy .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Histologic confirmation Multiple Myeloma Patients intend treated myeloablative therapy autologous hematopoetic stemcell transplant within one month stemcell collection Patients whose stemcell mobilization regimen include GCSF ( granulocytecolony stimulate factor ) Males nonpregnant female , 18 year age old Karnofsky score ≥70 % Patients premobilization platelet count &lt; 75,000/µL Patients receive pelvic bone marrow irradiation part condition therapy Patients previous hematopoetic stemcell transplant Patients previous hematopoetic stemcell collection failure Impaired cardiac function , evidence left ventricular ejection fraction &lt; 40 % . Impaired hepatic function , evidence alanine transaminase &gt; 2.5 x normal Impaired pulmonary function evidence diffusion capacity lung carbon monoxide ( adjust patient hematocrit , indicate ) force expiratory volume 1 second &lt; 50 % predict Impaired renal function , evidence creatinine clearance &lt; 40 mL/min Impaired coagulation , evidence prothrombin time ( PT ) &gt; twice normal Pregnancy lactation Seropositivity Human Immunodeficiency Virus1/2 , Hepatitis B Virus , Hepatitis C Virus Documented bacterial fungal infection require intravenous antibiotic start continued undergoing apheresis collection Spectra Optia device Subjects enrol study protocol could affect number CD34+ cell ( pluripoten hematopoetic stem stells ) collect kinetics neutrophil recovery Altered mental status , evidence inability provide effective informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>